Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant human thrombin (rhThrombin)

thrombin · Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant human thrombin (rhThrombin), covering 2022-11-29 to 2022-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Topical Recombinant Human Thrombin(rhThrombin) for Surgical Hemostasis [Phase 3]

See pricing